Financial Architects (New Jersey)’s Kyntra Bio KYNB Stock Holding History

Financial Architects (New Jersey)’s Portfolio KYNB Stock Details KYNB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-6	Closed	-$6K	–	869
2019 Q4	$6K	Hold	6	–	–	﹤0.01%	740
2019 Q3	$6K	Hold	6	–	–	﹤0.01%	800
2019 Q2	$7K	Hold	6	–	–	﹤0.01%	949
2019 Q1	$8K	Hold	6	–	–	﹤0.01%	1136
2018 Q4	$7K	Hold	6	–	–	﹤0.01%	1064
2018 Q3	$9K	Hold	6	–	–	﹤0.01%	1130
2018 Q2	$9K	Hold	6	–	–	﹤0.01%	1010
2018 Q1	$7K	Hold	6	–	–	﹤0.01%	1172
2017 Q4	$7K	Hold	6	–	–	﹤0.01%	1224
2017 Q3	$8K	Hold	6	–	–	﹤0.01%	1177
2017 Q2	$5K	Hold	6	–	–	﹤0.01%	1273
2017 Q1	$4K	Hold	6	–	–	﹤0.01%	1325
2016 Q4	$3K	Sell	6 -25	-81%	-$12.5K	﹤0.01%	1235
2016 Q3	$16K	Hold	31	–	–	﹤0.01%	891
2016 Q2	$13K	Sell	31 -4	-11%	-$1.83K	﹤0.01%	904
2016 Q1	$19K	Buy	+35	New	+$17.4K	0.01%	595
2015 Q3	–	Sell	-115	Closed	-$68K	–	461
2015 Q2	$68K	Buy	115 +55	+92%	+$32K	0.02%	377
2015 Q1	$47K	Buy	60 +46	+329%	+$35.7K	0.02%	408
2014 Q4	$10K	Buy	+14	New	+$9.01K	﹤0.01%	670

Other funds holding KYNB

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return

HHLR Advisors Grand Cayman, Cayman Islands $832M AUM 32.38% 1-Year Est. Return

Janus Henderson Group London $209B AUM 37.72% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

FCM

Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Financial Architects (New Jersey)'s KYNB Position: Q1 2020 in Review

Financial Architects (New Jersey) sold out of Kyntra Bio (KYNB) in Q1 2020, closing a stake of 6 shares — an estimated $6K sold.

Financial Architects (New Jersey) first reported a position in KYNB in Q4 2014 and held it in 19 quarters. The position peaked at $68K in Q2 2015. 187 funds tracked by Wall St. Rank hold KYNB as of Q1 2020.

Financial Architects (New Jersey) reported no remaining Kyntra Bio position as of Q1 2020 after selling out during the quarter.
Financial Architects (New Jersey) sold 6 Kyntra Bio shares in Q1 2020, an estimated $6K.
Financial Architects (New Jersey) first reported a position in Kyntra Bio in Q4 2014 and held it in 19 quarters.
Financial Architects (New Jersey)'s Kyntra Bio position peaked at $68K in Q2 2015.
187 funds tracked by Wall St. Rank held Kyntra Bio as of Q1 2020.

Based on Financial Architects (New Jersey)'s 13F filing for Q1 2020, filed 7 May 2020.